Natco Pharma strengthens on receiving nod to sell US-based pharmacy stores

31 Mar 2016 Evaluate

Natco Pharma is currently trading at Rs. 417.50, up by 18.30 points or 4.58% from its previous closing of Rs. 399.20 on the BSE.

The scrip opened at Rs. 405.25 and has touched a high and low of Rs. 425.20 and Rs. 405.25 respectively. So far 1,72,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 623.60 on 05-Jan-2016 and a 52 week low of Rs. 365.79 on 28-Apr-2015.

Last one week high and low of the scrip stood at Rs. 438.80 and Rs. 390.00 respectively. The current market cap of the company is Rs. 7,263.00 crore.

The promoters holding in the company stood at 51.31% while Institutions and Non-Institutions held 26.41% and 22.28% respectively.

Natco Pharma has received its board's approval for the sale of Save Mart Pharmacy Stores located in USA, which is a non-core business of the Company. The Save Mart Pharmacy Stores is being owned by Natco Pharma Inc, a wholly owned subsidiary of the Company.

Natco Pharma is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). Its operating segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others.


Natco Pharma Share Price

902.35 5.30 (0.59%)
31-Dec-2025 14:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.50
Dr. Reddys Lab 1273.00
Cipla 1510.95
Zydus Lifesciences 914.50
Lupin 2113.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×